株式会社レボルカ （RevolKa）は最先端バイオ製品のコアとなるタンパク質を人工知能で育て進化させ提供することにより世界の人々の「健康」と「豊かさ」に貢献します。
Investors 1
| Date | Name | Website |
| 06.04.2022 | MAKOTO CAP... | mkto-capit... |
Mentions in press and media 1
| Date | Title | Description |
| 30.08.2024 | RevolKa Closes US$1.7M Series A Extension Funding | RevolKa, a Tokyo, Japan-based biotech company advancing an AI-driven protein engineering technology platform, raised US$0.7M and completed a US$1.7M in Series A funding. D3 co-led the Series A extension round along with DEEPCORE. The compan... |